Enhanced miR-210 expression promotes the pathogenesis of endometriosis through activation of signal transducer and activator of transcription 3

Human Reproduction

Volumn 30, Issue 3, 2015, Pages 632-641

  Okamoto, M ^a   Nasu, K ^a,b   Abe, W ^a   Aoyagi, Y ^a   Kawano, Y ^a   Kai, K ^a   Moriyama, M ^a   Narahara, H ^a  

^a OITA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

endometriosis; microRNA; Signal transducer and activator of transcription 3; Vascular endothelial growth factor

Indexed keywords

3 (6 BROMO 2 PYRIDINYL) 2 CYANO N (1 PHENYLETHYL)ACRYLAMIDE; 4 [[(4 METHYLPHENYL)SULFONYLOXY]ACETAMIDO]SALICYLIC ACID; BLOOD CLOTTING FACTOR 8; CASPASE 3; CASPASE 7; CD45 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CRYPTOTANSHINONE; CYTOKERATIN; HISTONE DEACETYLASE 2; MESSENGER RNA; MICRORNA 210; S6 KINASE; STAT3 PROTEIN; STAT6 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SYNAPTOPODIN; THROMBOSPONDIN; UROKINASE; VASCULOTROPIN; VASCULOTROPIN A; VIMENTIN; MICRORNA; MIRN210 MICRORNA, HUMAN; PYRIDINE DERIVATIVE; STAT3 PROTEIN, HUMAN; TYRPHOSTIN;

ADULT; ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADULT; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PYRIDINES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TYRPHOSTINS;

EID: 84935106340     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu332     Document Type: Article

References (49)

1. Abe W, Nasu K, Nakada C, Kawano Y, Moriyama M, Narahara H. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells. Hum Reprod 2013;28:750-761.
2. Adammek M, Greve B, Kässens N, Schneider C, Brüggemann K, Schüring AN, Starzinski-Powitz A, Kiesel L, Götte M. Micro RNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors. Fertil Steril 2013;99:1346-1355. e5.
3. Bartel DP. Micro RNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
4. Braza-Böils A, Maŕi-Alexandre J, Gilabert J, Sánchez-Izquierdo D, España F, Estellés A, Gilabert-Estellés J. Micro RNA expression profile in endo-metriosis: its relation to angiogenesis and fibrinolytic factors. Hum Reprod 2014;29:978-988.
5. Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL, Ragoussis J. microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 2011; 71:5635-5645.
6. Burney RO, Hamilton AE, Aghajanova L, Vo KC, Nezhat CN, Lessey BA, Giudice LC. Micro RNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis. Mol Hum Reprod 2009;15:625-631.
7. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J. Micro RNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 2009;10:273-284.
8. Committee of the American Society for Reproductive Medicine. Endometriosis and infertility. Fertil Steril 2004;81:1441-1446.
9. Crosby ME, Kulshreshtha R, Ivan M, Glazer PM. Micro RNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 2009; 69:1221-1229.
10. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13:1686-1690.
11. Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006;25:6163-6169.
12. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F. Micro RNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 2008;283:15878-15883.
13. Ferrajoli A, Faderl S, Van Q, Koch P, Harris D, Liu Z, Hazan-Halevy I, Wang Y, Kantarjian HM, Priebe W et al. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer Res 2007;67:11291-11299.
14. Filigheddu N, Gregnanin I, Porporato PE, Surico D, Perego B, Galli L, Patrignani C, Graziani A, Surico N. Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotech 2010;2010:369549.
15. Fletcher S, Singh J, Zhang X, Yue P, Page BD, Sharmeen S, Shahani VM, Zhao W, Schimmer AD, Turkson J et al. Disruption of transcriptionally active Stat3 dimers with non-phosphorylated, salicylic acid-based small molecules: potent in vitro and tumor cell activities. Chembiochem 2009; 10:1959-1964.
16. Furqan M, Akinleye A, Mukhi N, Mittal V, Chen Y, Liu D. STAT inhibitors for cancer therapy. J Hematol Oncol 2013;6:90.
17. Gambari R, Fabbri E, Borgatti M, Lampronti I, Finotti A, Brognara E, Bianchi N, Manicardi A, Marchelli R, Corradini R. Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development. Biochem Pharmacol 2011;82:1416-1429.
18. Gee HE, Camps C, Buffa FM, Patiar S, Winter SC. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010;116:2148-2158.
19. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
20. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799.
21. Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH, Matzuk MM. Functional Micro RNA involved in endometriosis. Mol Endocrinol 2011;25:821-832.
22. Hemida MG, Ye X, Thair S, Yang D. Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations. Mol Diagn Ther 2010;14:271-282.
23. Hsu CY, Hsieh TH, Tsai CF, Tsai HP, Chen HS, Chang Y, Chuang HY, Lee JN, Hsu YL, Tsai EM. miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis. J Pathol 2014;232:330-343.
24. Huang X, Le Q-T, Giaccia AJ. Mi R-210-micromanager of the hypoxia pathway. Trends Mol Med 2010;16:230-237.
25. Karmon AE, Cardozo ER, Rueda BR, Styer AK. Micro RNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention? Hum Reprod Update 2014;20:670-687.
26. Kota SK, Balasubramanian S. Cancer therapy via modulation of micro RNA levels: a promising future. Drug Discov Today 2010;15:733-740.
27. Kuokkanen S, Chen B, Ojalvo L, Benard L, Santoro N, Pollard JW. Genomic profilingof microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod 2010; 82:791-801.
28. Langleben A, Supko JG, Hotte SJ, Batist G, Hirte HW, Rogoff H, Li Y, Li W, Kerstein D, Leggett D et al. A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies. J Clin Oncol 2013;31(Suppl):abstr 2542.
29. Laurie SA, Jonker DJ, Edenfield WJ, Stephenson J, Keller D, Hitron M, Li W, Li Y, Gada K, Gao Y et al. A phase 1 dose-escalation study of BBI503, a first-in-class cancer stemness kinase inhibitor in adult patients with advanced solid tumors. J Clin Oncol 2014;32(suppl):abstr 2527.
30. Lin S-C, Li Y-H, Wu M-H, Chang Y-F, Lee D-K, Tsai SY, Tsai M-J, Tsai S-J. Suppression of COUP-TFII by Proinflammatory Cytokines Contributes to the Pathogenesis of Endometriosis. J Clin Endocrinol Metab 2014; 99:E427-E437.
31. Lin SC, Wang CC, Wu MH, Yang SH, Li YH, Tsai SJ. Hypoxia-induced microRNA-20a expression increases ERK phosphorylation and angiogenic gene expression in endometriotic stromal cells. J Clin Endocrinol Metab 2012;97:E1515-E1523.
32. Lu L, Li C, Li D, Wang Y, Zhou C, Shao W, Peng J, You Y, Zhang X, Shen X. Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling. Mol Cell Biochem 2013;381:273-282.
33. Nasu K, Kawano Y, Tsukamoto Y, Takano M, Takai N, Li H, Furukawa Y, Abe W, Moriyama M, Narahara H. Aberrant DNA methylation status of endometriosis: epigenetics as the pathogenesis, biomarker and therapeutic target. J Obstet Gynaecol Res 2011a;37:683-695.
34. Nasu K, Nishida M, Kawano Y, Tsuno A, Abe W, Yuge A, Takai N, Narahara H. Aberrant expression of apoptosis-related molecules in endometriosis: a possible mechanism underlying the pathogenesis of endometriosis. Reprod Sci 2011b;18:206-218.
35. Nasu K, Kawano Y, Kai K, Aoyagi Y, Abe W, Okamoto M, Narahara H. Aberrant histone modification in endometriosis. Front Biosci 2014; 19:1202-1214.
36. Nishida M, Nasu K, Fukuda J, Kawano Y, Narahara H, Miyakawa I. Down regulation of interleukin-1 receptor expression causes the dysregulated expression of CXC chemokines in endometriotic stromal cells: a possible mechanism for the altered immunological functions in endometriosis. J Clin Endocrinol Metab 2004;89:5094-5100.
37. Noman MZ, Buart S, Romero P, Ketari S, Janji B, Mari B, Mami-Chouaib F, Chouaib S. Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Cancer Res 2012;72: 4629-4641.
38. Ohlsson Teague EMC, Van der Hoek KH, Van der Hoek MB, Perry N, Wagaarachchi P, Robertson SA, Print CG, Hull ML. Micro RNA-regulated pathways associated with endometriosis. Mol Endocrinol 2009; 23:265-275.
39. Ohlsson Teague EMC, Print CG, Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update 2010;16:142-165.
40. Pan Q, Luo X, Toloubeydokhti T, Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007;13:797-806.
41. Pillai RS. Micro RNA function: multiple mechanisms for a tiny RNA? RNA 2005;11:1753-1761.
42. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002;32(Suppl):496-501.
43. Shen L, Yang S, Huang W, Xu W, Wang Q, Song Y, Liu Y. Micro RNA23a and microRNA23b deregulation derepresses SF-1 and upregulates estrogen signaling in ovarian endometriosis. J Clin Endocrinol Metab 2013; 98:1575-1582.
44. Shi XY, Gu L, Chen J, Guo XR, Shi YL. Downregulation of miR-183 inhibits apoptosis and enhances the invasive potential of endometrial stromal cells in endometriosis. Int J Mol Med 2014;33:59-67.
45. Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, Tan BK, Sethi G, Bishayee A. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta 2014;1845: 136-154.
46. Stephen YC, Joseph L. Micro RNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010;9:1072-1083.
47. Toloubeydokhti T, Pan Q, Luo X, Bukulmez O, Chegini N. The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod Sci 2008;15:993-1001.
48. Yuk CC, Jaideep B, Sang YC, Chandan KS. miR-210: the master hypoxamir. Microcirculation 2012;19:215-223.
49. Zhang Z, Sun H, Dai H, Walsh RM, Imakura M, Schelter J, Burchard J, Dai X, Chang AN, Diaz RL et al. Micro RNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 2009;8: 2756-2768.